These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 37179139)
41. Absence of Pathogenic Mutations and Strong Association With HLA-DRB1*11:01 in Statin-Naïve Early-Onset Anti-HMGCR Necrotizing Myopathy. Llansó L; Segarra-Casas A; Domínguez-González C; Malfatti E; Kapetanovic S; Rodríguez-Santiago B; de la Calle O; Blanco R; Dobrescu A; Nascimento-Osorio A; Paipa A; Hernandez-Lain A; Jou C; Mariscal A; González-Mera L; Arteche A; Lleixà C; Caballero-Ávila M; Carbayo Á; Vesperinas A; Querol L; Gallardo E; Olivé M Neurol Neuroimmunol Neuroinflamm; 2024 Sep; 11(5):e200285. PubMed ID: 39106428 [TBL] [Abstract][Full Text] [Related]
42. Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum". Hamann PD; Cooper RG; McHugh NJ; Chinoy H Autoimmun Rev; 2013 Oct; 12(12):1177-81. PubMed ID: 23851103 [TBL] [Abstract][Full Text] [Related]
43. Statin-associated immune-mediated necrotising myopathy: a New Zealand case series showing possible overrepresentation in Pacific Islanders. Woolley M; Stebbings S; Highton J Intern Med J; 2018 Jan; 48(1):32-36. PubMed ID: 28782163 [TBL] [Abstract][Full Text] [Related]
44. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan. Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171 [TBL] [Abstract][Full Text] [Related]
46. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019 [TBL] [Abstract][Full Text] [Related]
47. Immune-mediated necrotizing myopathy: clinical features and pathogenesis. Allenbach Y; Benveniste O; Stenzel W; Boyer O Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664 [TBL] [Abstract][Full Text] [Related]
48. A Case of Statin-Associated Autoimmune Myopathy: Management and Treatment. Malone M; Lahmar A; Siddique A; Rozboril M; Kresak JL J Prim Care Community Health; 2023; 14():21501319221148635. PubMed ID: 36688423 [TBL] [Abstract][Full Text] [Related]
49. Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the Disease. Szczesny P; Barsotti S; Nennesmo I; Danielsson O; Dastmalchi M Front Immunol; 2022; 13():866701. PubMed ID: 35603214 [TBL] [Abstract][Full Text] [Related]
50. Patient with statin-associated immune-mediated necrotizing myopathy presenting with subcutaneous edema, persistent bulbar weakness and absent anti-HMGCR. Ong SG; Ding HJ Int J Rheum Dis; 2017 Dec; 20(12):2175-2178. PubMed ID: 26692320 [No Abstract] [Full Text] [Related]
51. A Case of Statin-Associated Immune-Mediated Necrotizing Myopathy. Zuo D J Clin Rheumatol; 2023 Aug; 29(5):e115-e116. PubMed ID: 37106482 [No Abstract] [Full Text] [Related]
52. Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data. Rademacher JG; Glaubitz S; Zechel S; Oettler M; Tampe B; Schmidt J; Korsten P Clin Exp Rheumatol; 2022 Feb; 40(2):320-328. PubMed ID: 35225222 [TBL] [Abstract][Full Text] [Related]
53. Statin Induced Immune Mediated Necrotizing Myopathy: More Than Just Sore Muscles. Newton J; Simmons M S D Med; 2023 Jan; 76(1):28-30. PubMed ID: 36897787 [TBL] [Abstract][Full Text] [Related]
54. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed. Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376 [TBL] [Abstract][Full Text] [Related]
55. Immune-mediated necrotising myopathy: a rare cause of hyperCKaemia. Liang E; Rastegar M BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29691272 [TBL] [Abstract][Full Text] [Related]
60. Statins as a possible cause of inflammatory and necrotizing myopathies. Padala S; Thompson PD Atherosclerosis; 2012 May; 222(1):15-21. PubMed ID: 22154355 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]